A medical device which facilitates the diagnosis and follow-up of respiratory diseases
COVID-19
Our studies show that respiratory diseases have their own “acoustic signature” identifiable by artificial intelligence better than by the human ear.
Authorities in 221 countries and territories have reported about 225.5 million Covid‑19 cases and 4.65 million deaths since December 2019. Our AI-driven stethoscope can determine who is affected, predict the outcome of the pulmonary disease in hospitalized patients, alert those confined at home and their doctor by telemedicine when their situation deteriorates. Overall medical management and health costs could be tremendously improved.
Asthma
Asthma affects 350 million people and is the leading chronic disease in children. People with asthma get difficulties to objectively define the severity of symptoms. Fear, anxiety and isolation considerably impair judgement, this is even more exacerbated for a parent who sees his asthmatic child starting an attack.
By using our AI-driven stethoscope, each parent will be able to objectively assess the severity of symptoms, be advised in real time on the treatment and the need of a medical consultation to make the best choice for their child’s health.
Pneumonia
According to the World Health Organization (WHO), 1 million children die every year due to pneumonia. 16% of overall deaths occurs in children under five, 80% within the first two years of life. In low resources settings doctors are scarce and Health Care Workers (HCW) poorly trained to diagnose pneumonia, often leading to patients’ death or to antibiotic overuse.
Our AI-driven stethoscope facilitates HCWs clinical decision-making saving millions of lives every year in cities as in remote areas of low-and-middle income countries.
A simple 3 steps process

Recording lung sounds by placing the device on the patient’s chest
Real-time analysis with Artificial Intelligence
Information on diagnosis, therapeutics and follow-up